Page 152 - MEMORIA ANUAL 2019 SEHH-FEHH

GRUPO ESPAñOL DE LINFOMAS Y TRASPLANTE AUTóLOGO DE MéDULA óSEA (GELTAMO)
MEMORIA ANUAL 2019
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
Presentaciones orales en congresos internacionales
• López-Parra M, Bellei M, Rambaldi A, Novelli S, Panizo C, Martelli M, Dhouly I, Bas- tos M, Gutiérrez A, Sancho JM, Ramírez M, Moraleda J, Carrillo Cruz E, Jiménez Ubie- to A, Jarque I, Vittolo U, de las Heras N, Arranz R, López-Jiménez J, Montalbán C, Pascual M, Corradini P, Bobillo S, Estefanía G, Spina M, Rossi G, Manni M, Federico M, Caballero D, Martín A. Peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study. 15th International Conference on Malignant Lymphoma. Lugano, 2017. Hema- tol Oncol. 2019;37(S2):98-9. Abstract 057.
• Baile M, Barrena S, Sancho JM, Grande C, Fernández R, Batlle A, Peñarrubia M, Peñalver F, Hernández-Rivas J, Guinea M, Pérez J, García-Álvarez M, Alcoceba M, Vi- driales B, Orfao A, Martín A. Evaluation of bone marrow infiltration by multidimen- sional flow cytometry in patients with diffuse large B-cell lymphoma: Substudy of a phase 2 GELTAMO clinical trial. 15th International Conference on Malignant Lymphoma. Lugano, 2017. Hematol Oncol. 2019;37(S2):362-3. Abstract 312.
• Ribera JM, García O, Cervera M, Rodríguez C, Sirvent M, Vall-Llovera F, Abrisqueta P, Serrano J, Buendía B, Montesinos Fernández P, Vives S, Bergua Burgues JM, Bas- tos-Oreiro MB, Acuña E, Moreno MJ, García-Cadenas I, Terol MJ, Hernández Rivas JM, García-Guiñón A, Herrera Puente P, Mercadal S, Iván I, Cladera A, Gimeno Vázquez E, Torrent A, Serrano-Maestro A, Barrenetxea C, García D, Arranz R, Sebrango A, Alonso N, Martínez-Carballeira D, Sancho JM. Rituximab and Specific Therapy for Patients with Burkitt’s Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients. 61st American Society of Hematology (ASH) Annual Meeting & Exposition. Orlando, Florida (USA), December 2019.
• Bento L, Ros T, Muncunill J, Asensio V, Fernández C, Quintero AM, Sas A, Martínez-Se- rra J, Sánchez-González B, Vögler O, Pérez S, García-Recio M, Jiménez-Julià SA, Aspas G, Del Campo R, Ibarra J, Ramos R, Salar A, Sampol A, Alemany R, Gutiérrez A. Analysis of Micro-RNAs Associated to Treatment Failure in Diffuse Large B Cell Lymphoma. 61st ASH Annual Meeting & Exposition. Orlando, Florida (USA), December 2019.
• Gine E, De La Cruz MF, Grande C, López Jiménez J, Martín A, Terol MJ, González- Barca E, de la Fuente A, Marín Niebla A, Casanova M, Muntañola Prat A, González- López TJ, Aymerich M, Palacios L, Setoain X, Cortés-Romera M, Rotger A, Medina A, García-Sanz R, Campo E, López-Guillermo A. Efficacy and Safety of Ibrutinib in Combination with Rituximab As Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma (MCL): Preliminary Results of Geltamo IMCL-2015
152